Jung Hyun Kwon Selected Research

Epirubicin (Ellence)

4/2020	Transarterial Infusion of Epirubicin and Cisplatin Combined With Systemic Infusion of 5-Flurouracil Versus Sorafenib for Hepatocellular Carcinoma With Refractoriness of Transarterial Chemoembolization Using Doxorubicin.
10/2017	Transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-fluorouracil versus transarterial chemoembolization using doxorubicin for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung Hyun Kwon Research Topics

Disease

33	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2009
19	Neoplasms (Cancer) 05/2024 - 09/2010
16	Chronic Hepatitis B 05/2024 - 01/2015
15	Fibrosis (Cirrhosis) 02/2024 - 01/2010
12	Infections 05/2024 - 03/2008
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2009
5	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2009
5	Chronic Hepatitis C 01/2023 - 09/2009
4	Thrombosis (Thrombus) 09/2023 - 02/2013
4	Liver Diseases (Liver Disease) 12/2019 - 03/2009
4	Hemorrhage 09/2019 - 12/2005
4	Inflammation (Inflammations) 01/2019 - 11/2013
4	Hepatitis B 01/2015 - 01/2013
3	Chronic Hepatitis (Chronic Active Hepatitis) 02/2024 - 01/2019
3	Asthma (Bronchial Asthma) 10/2022 - 06/2015
3	Viremia 01/2021 - 12/2019
3	Liver Neoplasms (Liver Cancer) 04/2020 - 09/2010
2	Hypertension (High Blood Pressure) 05/2024 - 05/2015
2	Disease Progression 01/2021 - 12/2019
2	Atopic Dermatitis (Atopic Eczema) 01/2021 - 06/2015
2	Insulin Resistance 11/2015 - 03/2009
2	Pulmonary Hypertension 03/2014 - 03/2013
1	Chemical and Drug Induced Liver Injury 03/2023
1	Hepatitis C 01/2023
1	Pneumonia (Pneumonitis) 10/2022
1	Chronic Renal Insufficiency 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 09/2021
1	Hepatorenal Syndrome 09/2021
1	Esophageal and Gastric Varices (Esophageal Varices) 09/2019
1	Brain Neoplasms (Brain Tumor) 06/2019
1	Acute-On-Chronic Liver Failure 12/2018
1	Renal Insufficiency (Renal Failure) 10/2018

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2013
6	Tenofovir (Viread)FDA Link 05/2024 - 01/2015
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2024 - 01/2015
5	entecavir FDA Link 01/2021 - 01/2015
5	CytokinesIBA 01/2020 - 12/2012
4	Sorafenib (BAY 43-9006)FDA Link 06/2023 - 04/2020
4	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2010
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2012
3	Hepatitis B e AntigensIBA 02/2024 - 01/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 12/2018
3	AlbuminsIBA 09/2021 - 12/2012
3	C-Reactive ProteinIBA 10/2015 - 12/2012
3	MonocrotalineIBA 05/2015 - 03/2013
2	lenvatinibIBA 01/2024 - 12/2020
2	Cytidine Triphosphate (CTP)IBA 01/2022 - 10/2018
2	nasIBA 01/2021 - 01/2021
2	InterferonsIBA 01/2021 - 03/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 07/2018
2	EnzymesIBA 01/2021 - 01/2019
2	Epirubicin (Ellence)FDA LinkGeneric 04/2020 - 10/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2020 - 10/2017
2	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 10/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2014
2	BilirubinIBA 10/2018 - 12/2016
2	Carrier Proteins (Binding Protein)IBA 07/2018 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 07/2018 - 02/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2018 - 11/2016
2	Indicators and Reagents (Reagents)IBA 10/2015 - 12/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2014 - 03/2013
2	Interleukin-10 (Interleukin 10)IBA 11/2013 - 12/2012
2	Fetal Proteins (Fetoprotein)IBA 02/2013 - 12/2012
2	Ribavirin (Virazole)FDA LinkGeneric 03/2011 - 09/2009
2	Pepsinogen A (Pepsinogen)IBA 03/2008 - 08/2007
1	Serum AlbuminIBA 05/2024
1	tenofovir alafenamideIBA 05/2024
1	atezolizumabIBA 09/2023
1	Bevacizumab (Avastin)FDA Link 09/2023
1	Immune Checkpoint InhibitorsIBA 03/2023
1	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2023
1	velpatasvirIBA 01/2023
1	SofosbuvirIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 11/2022
1	CM 2-3IBA 01/2022
1	Hexosaminidases (Hexosaminidase)IBA 09/2021
1	TerlipressinIBA 09/2021
1	thiamine triphosphorate (TTP)IBA 02/2021
1	Heavy MetalsIBA 01/2021
1	CollagenIBA 01/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Interleukin-22 (IL-22)IBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	asunaprevirIBA 01/2019
1	daclatasvirIBA 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	Interleukin-9 (Interleukin 9)IBA 01/2019
1	Thrombospondin 1IBA 01/2019
1	EndostatinsIBA 01/2019

Therapy/Procedure

22	Therapeutics 09/2023 - 09/2009
4	Radiotherapy 09/2023 - 09/2010
3	Radiofrequency Ablation 03/2023 - 12/2019
3	Liver Transplantation 03/2023 - 02/2021
3	Drug Therapy (Chemotherapy) 01/2020 - 11/2013
2	Renal Dialysis (Hemodialysis) 01/2019 - 06/2008
2	Drug Tapering 03/2011 - 12/2005
1	Hepatectomy 12/2019
1	Ligation 09/2019
1	Conservative Treatment 06/2019